Academic literature on the topic 'Protein S'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Protein S.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Protein S"

1

Sorice, M., T. Griggi, A. Circella, et al. "Protein S antibodies in acquired protein S deficiencies [letter]." Blood 83, no. 8 (1994): 2383–84. http://dx.doi.org/10.1182/blood.v83.8.2383b.2383b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sorice, M., T. Griggi, A. Circella, et al. "Protein S antibodies in acquired protein S deficiencies [letter]." Blood 83, no. 8 (1994): 2383–84. http://dx.doi.org/10.1182/blood.v83.8.2383b.bloodjournal8382383b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sacchi, E., M. Pinotti, G. Marchetti, et al. "Protein S mRNA in Patients with Protein S Deficiency." Thrombosis and Haemostasis 73, no. 05 (1995): 746–49. http://dx.doi.org/10.1055/s-0038-1653862.

Full text
Abstract:
SummaryA protein S gene polymorphism, detectable by restriction analysis (BstXI) of amplified exonic sequences (exon 15), was studied in seven Italian families with protein S deficiency. In the 17 individuals heterozygous for the polymorphism the study was extended to platelet mRNA through reverse transcription, amplification and densitometric analysis. mRNA produced by the putative defective protein S genes was absent in three families and reduced to a different extent (as expressed by altered allelic ratios) in four families. The allelic ratios helped to distinguish total protein S deficienc
APA, Harvard, Vancouver, ISO, and other styles
4

Kwaan, Hau. "Protein C and Protein S." Seminars in Thrombosis and Hemostasis 15, no. 03 (1989): 353–55. http://dx.doi.org/10.1055/s-2007-1002728.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Esmon, Charles T. "Protein S and protein C." Trends in Cardiovascular Medicine 2, no. 6 (1992): 214–19. http://dx.doi.org/10.1016/1050-1738(92)90027-p.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rick, Margaret E. "Protein C and Protein S." JAMA 263, no. 5 (1990): 701. http://dx.doi.org/10.1001/jama.1990.03440050095041.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nelson, R. M., and G. L. Long. "Binding of protein S to C4b-binding protein. Mutagenesis of protein S." Journal of Biological Chemistry 267, no. 12 (1992): 8140–45. http://dx.doi.org/10.1016/s0021-9258(18)42418-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bertina, R. M., A. van Wijngaarden, J. Reinalda-Poot, S. R. Poort, and V. J. J. Bom. "Determination of Plasma Protein S - The Protein Cofactor of Activated Protein C." Thrombosis and Haemostasis 53, no. 02 (1985): 268–72. http://dx.doi.org/10.1055/s-0038-1661291.

Full text
Abstract:
SummaryProtein S, an important cofactor of activated protein C, and C4b-binding protein were purified from human plasma. Specific antibodies against the purified proteins were raised in rabbits and used for the development of immunologic assays for these proteins in plasma: an immunoradiometric assay for protein S (which measures both free protein S and protein S complexed with C4b-binding protein) and an electroimmunoassay for C4b- binding protein. Ranges for the concentrations of these proteins were established in healthy volunteers and patients using oral anticoagulant therapy. A slight dec
APA, Harvard, Vancouver, ISO, and other styles
9

NAKAYAMA, Takayuki, and Tetsuhito KOJIMA. "Protein S Deficiency." Japanese Journal of Thrombosis and Hemostasis 12, no. 3 (2001): 235–39. http://dx.doi.org/10.2491/jjsth.12.235.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Zhang, Mingzi M., and Howard C. Hang. "Protein S-palmitoylation in cellular differentiation." Biochemical Society Transactions 45, no. 1 (2017): 275–85. http://dx.doi.org/10.1042/bst20160236.

Full text
Abstract:
Reversible protein S-palmitoylation confers spatiotemporal control of protein function by modulating protein stability, trafficking and activity, as well as protein–protein and membrane–protein associations. Enabled by technological advances, global studies revealed S-palmitoylation to be an important and pervasive posttranslational modification in eukaryotes with the potential to coordinate diverse biological processes as cells transition from one state to another. Here, we review the strategies and tools to analyze in vivo protein palmitoylation and interrogate the functions of the enzymes t
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Protein S"

1

Hon, Jiří. "Vyhledávání příbuzných proteinů s modifikovanou funkcí." Master's thesis, Vysoké učení technické v Brně. Fakulta informačních technologií, 2015. http://www.nusl.cz/ntk/nusl-234914.

Full text
Abstract:
Protein engineering is a young dynamic discipline with great amount of potential practical applications. However, its success is primarily based on perfect knowledge and usage of all existing information about protein function and structure. To achieve that, protein engineering is supported by plenty of bioinformatic tools and analysis. The goal of this project is to create a new tool for protein engineering that would enable researchers to identificate related proteins with modified function in still growing biological databases. The tool is designed as an automated workflow of existing bioin
APA, Harvard, Vancouver, ISO, and other styles
2

He, Xuhua. "Vitamin K-dependent anticoagulant protein S biochemical and histochemical studies /." Lund : Dept. of Clinical Chemistry, Wallenberg Laboratory, University of Lund, University Hospital MAS, 1994. http://catalog.hathitrust.org/api/volumes/oclc/39693810.html.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Radu, Claudia Maria. "Study of the origin of platelets coagulation protein S by human megakaryocyte cultures and characterization of platelets protein S in patients with inherited protein S deficiency." Doctoral thesis, Università degli studi di Padova, 2009. http://hdl.handle.net/11577/3426476.

Full text
Abstract:
Protein S (PS) is a vitamin K dependent plasma glycoprotein with multiple functions in coagulation, inflammation and apoptosis. The molecular weight of PS is approximately 70 kDa and its concentration in plasma is about 25 mg/L. In human plasma 40% of PS circulates as free form and the remaining 60% is complexes with complement C4b-binding protein, a component of the complement system. PS circulating in plasma is mainly derived from liver synthesis but, in addition, endothelial cells, testicular Leydig cells and a megakaryocytic cell line (MEG 01) can synthesize PS. Platelet contain PS, but wh
APA, Harvard, Vancouver, ISO, and other styles
4

Wardlaw, Christopher. "Protein-protein interactions underlying damage checkpoint activation in S. pombe." Thesis, University of Sussex, 2014. http://sro.sussex.ac.uk/id/eprint/48121/.

Full text
Abstract:
DNA damage can lead to the accumulation of mutations and diseases such as cancer. It is therefore integral for cells to identify this damaged DNA and promote its repair. To carry out this function eukaryotic cells have evolved signal transduction pathways known as the DNA structure checkpoints. Much of the molecular mechanism underlying these pathways is still far from understood. The work in this thesis uses the model organism Schizosaccharomyces pombe to investigate these mechanisms, with a particular focus on the TopBP1 homolog Rad4. TopBP1 plays an essential scaffolding role in the initiat
APA, Harvard, Vancouver, ISO, and other styles
5

Simmonds, Rachel Elizabeth. "Protein S deficiency and familial thrombophilia." Thesis, Imperial College London, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.267993.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hamel, Laura Dawn. "Targeting Autopalmitoylation to Modulate Protein S-Palmitoylation." Scholar Commons, 2015. http://scholarcommons.usf.edu/etd/5960.

Full text
Abstract:
Palmitoylation refers to the covalent attachment of fatty acids, such as palmitate, onto the cysteine residues of proteins. This process may subsequently alter their localization and function. Nearly all of the enzymes that catalyze palmitoylation, zDHHC protein acyl transferases (PATs), are implicated in neurological disorders, infectious diseases, and cancer in humans. Of particular interest to those who study palmitoylation are Ras family GTPas and zDHHC9-GCP16, the zDHHC PAT that palmitoylates Ras proteins. Erf2-Erf4 is the zDHHC PAT that palmitoylates Ras proteins in Saccharomyces cerevis
APA, Harvard, Vancouver, ISO, and other styles
7

Hughes, Qunitin William. "Hormonal regulation of the anticoagulant Protein S." University of Western Australia. School of Surgery and Pathology, 2008. http://theses.library.uwa.edu.au/adt-WU2008.0247.

Full text
Abstract:
[Truncated abstract] Every year thousands of individuals suffer from thrombotic related complications that in some cases can be fatal and every year millions of women take some form of hormonal contraceptive. In some cases, there is a cause and effect relationship between the two as users of the combined oral contraceptive pill have an increased risk of developing a thrombotic event. Increased circulating levels of oestrogen cause a prothrombotic shift in the coagulation cascade resulting from upregulation of several procoagulant proteins and a decrease of key anticoagulant proteins. One of th
APA, Harvard, Vancouver, ISO, and other styles
8

Zheng, Bin. "RGS proteins : bridging the "GAP"s between G protein signaling and membrane trafficking /." Diss., Connect to a 24 p. preview or request complete full text in PDF format. Access restricted to UC campuses, 2002. http://wwwlib.umi.com/cr/ucsd/fullcit?p3059905.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Badgandi, Hemant B. "Biology Facilitated by Heme Proteins as Seen in Cimex Nitrophorin and Ecdysone Inducible Protein 75." Diss., The University of Arizona, 2009. http://hdl.handle.net/10150/196147.

Full text
Abstract:
This dissertation is a study in how heme facilitates biology using two heme proteins as examples. I write about my mechanistic studies on Cimex nitrophorin and preliminary studies on Ecdysone inducible protein 75, respectively. Nitrophorins are salivary heme proteins used by bloodfeeding insects to deliver NO to the victim, leading to vasodilation and antihemostasis. The bedbug nitrophorin cNP, a thiolate heme protein accomplishes this via an unusual heme-assisted S-nitrosation reaction, requiring proximal ligand cleavage. This dissertation explores this mechanism through mutational, cryst
APA, Harvard, Vancouver, ISO, and other styles
10

Rezende, Suely Meireles. "The molecular basis of hereditary protein S deficiency." Thesis, Imperial College London, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.289821.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Protein S"

1

M, Bertina Rogier, ed. Protein C and related proteins: Biochemical and clinical aspects. Churchill Livingstone, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cheung, Ricky W. K. The role of G-protein gbsgcs subunits in the invertebrate visual system. National Library of Canada = Bibliothèque nationale du Canada, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Trigazis, Leonidas. Involvement of cholecystokininbAs receptors in protein-induced satiety in rats. National Library of Canada = Bibliothèque nationale du Canada, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kaitho, Robert J. Nutritive value of browses as protein supplement(s) to poor quality roughages. [s.n.], 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Statistik, Indonesia Biro Pusat, ed. Konsumsi kalori dan protein penduduk Indonesia per provinsi, 1987: Consumption of calorie and protein of Indonesian[s] by province, 1987. Biro Pusat Statistik, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hearn, Melanie Jane. Identification and characterisation of a binding protein from pollen membranes for the Papaver rhoeas stigmatic self-incompatability [(S-)] proteins. University of Birmingham, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Abdel-Gawad, Yehia Mohamed. Nuclear protein changes in a murine model of myocarditis: The down regulation of histone H1ps, a differentiation - dependent protein. National Library of Canada, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

D'Agrosa, Raffaele Michael. The gbs galactosidase-neuraminidase-protective protein complex and associated lysosomal storage disorders. National Library of Canada, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bibby, Ashley C. Characterization of novel autoinhibitory site(s) within the protein kinase C alpha regulatory domain. Laurentian University, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cutz, Jean-Claude. Effect of amygdala kindling on G protein-coupled gas-subunit levels: Immunobolt and functional analysis. National Library of Canada, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Protein S"

1

Cooper, D. N., and M. Krawczak. "Protein S and protein S deficiency." In Venous Thrombosis. Garland Science, 2024. http://dx.doi.org/10.1201/9781003580102-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pötzsch, B. "Protein S." In Hämostaseologie. Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-662-07673-6_41.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Stief, T. "Protein S." In Lexikon der Medizinischen Laboratoriumsdiagnostik. Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-49054-9_2559-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Stief, T. "Protein S." In Springer Reference Medizin. Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_2559.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hepner, Mirta, and Vasiliki Karlaftis. "Protein S." In Haemostasis. Humana Press, 2013. http://dx.doi.org/10.1007/978-1-62703-339-8_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bertina, R. M. "Protein S antigen." In ECAT Assay Procedures A Manual of Laboratory Techniques. Springer Netherlands, 1992. http://dx.doi.org/10.1007/978-94-011-2992-3_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bertina, R. M. "Protein S antigen." In Laboratory Techniques in Thrombosis - a Manual. Springer Netherlands, 1999. http://dx.doi.org/10.1007/978-94-011-4722-4_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Faioni, E. M. "Protein S activity." In Laboratory Techniques in Thrombosis - a Manual. Springer Netherlands, 1999. http://dx.doi.org/10.1007/978-94-011-4722-4_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ward, Tony Milford. "Protein S-100." In Proteins and Tumour Markers May 1995. Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0681-8_73.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nakamura, Tomohiro, and Stuart A. Lipton. "Protein S-Nitrosylation." In Encyclopedia of Molecular Pharmacology. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-21573-6_10041-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Protein S"

1

Walker, F. J. "REGULATION OF THE ANTICOAGULANT ACTIVITY OF ACTIVATED PROTEIN C BY PROTEIN S AND PROTEIN S BINDING PROTEIN." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642964.

Full text
Abstract:
Protein S is a vitamin K-dependent protein that acts as a cofactor for the anticoagulant activity of activated protein C both in the proteolytic inactivation of factor V and VIII. Protein S is a single chain protein with a molecular weight of approximately 62 kDa. When the molecular weight of protein S in plasma was determined it was found to be much larger than the single chain protein. The molecular weight of functional protein S when measured by sedimentation equilibrium with the air-driven ultracentrifuge was observed to be between 115 and 130 kDa. In high salt or in the presence of copper
APA, Harvard, Vancouver, ISO, and other styles
2

Malm, J., R. Bennhagen, L. Holmberg, and B. Dahlbäck. "LOW PLASMA CONCENTRATIONS OF C4b-BINDING PROTEIN AND VITAMIN K-DEPENDENT PROTEIN S IN PRETERM INFANTS WITH DECREASED FORMATION OF PROTEIN S-C4b-BINDING PROTEIN COMPLEXES." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644265.

Full text
Abstract:
Protein S is a vitamin K-dependent plasmaprotein functioning as a non-enzymatic cofactor to the activated form of protein C in the degradation of coagulationfactors Va and VIIa. In the circulation approximately 60% of protein S is complexed to the complement protein C4b-binding protein (C4BP). Only the remaining, free fraction exhibits protein Ca cofactor activity.The plasma concentrations of protein S and C4BP were determined in 25 term and 26 preterm infants. Both proteins werequantified with radioimmunoassays. The free, functionally active form of proteinS and the total protein S concentrat
APA, Harvard, Vancouver, ISO, and other styles
3

Melissari, E., M. F. Scully, C. Parker, K. H. Nicolaides, and V. V. Kakkar. "PROTEIN C/PROTEIN S IN THE FOETAL BLOOD. ABSENCE OF BOUND PROTEINS AND C4 BINDING PROTEIN." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644290.

Full text
Abstract:
Protein C, free and bound protein S and C4 binding protein levels (C4bp), were measured by electroimmunoassay in 7 pregnant women aged 22-29 years at 16-18 weeks of gestation, immediately prior to termination of pregnancy for social reasons. Protein C and protein S levels were also measured in their foetuses from blood taken through the umbilical cord. In this group of pregnant women the mean levels for protein C were 104% of normal adult mean (range 80-128%), for C4bp 100% (52-150%), for free protein S 66% (43-89%). In the foetuses the mean value for protein C was 15.3% (10.5-21%) and for fre
APA, Harvard, Vancouver, ISO, and other styles
4

Comp, P. C., and C. T. Esmon. "Defects in the protein C pathway." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643715.

Full text
Abstract:
Activated protein C functions as an anticoagulant by enzymatically degrading factors Va and Villa in the clotting cascade. Protein C may be converted to its enzymatically active form bythrombin. The rate at which thrombin cleavage of the zymogen occurs is greatly enhanced when thrombin is bound to an endothelial cell receptor protein, thrombomodulin. Activated proteinC has a relatively long half-life in vivo and the formation of activated protein C in response to low level thrombin infusion suggests that the protein C system may provide a feedback mechanism to limit blood clotting. Clinical su
APA, Harvard, Vancouver, ISO, and other styles
5

Hopmeier, P., M. Halbmayer, H. P. Schwarz, F. Heuss, and M. Fischer. "PROTEIN C AND PROTEIN S IN MILD AND MODERATE PREECLAMPSIA." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644285.

Full text
Abstract:
In normal pregnancy, total protein S antigen and activity have been reported to be markedly reduced, whereas protein C level was found unaltered. In contrast, in severe preeclampsia protein C antigen was found to be considerably reduced. The presentstudy was done to clarify whether similar changes in protein Cwould alsobe observed for the mildand moderatepreeclamptic state andwhether there would be any effects on the level ofprotein S, since nodata on this cofactor in preeclampsia have been reported to date. 4-0 women in the 3rd trimester of pregnancy - 20 with uncomplicated pregnancies and 20
APA, Harvard, Vancouver, ISO, and other styles
6

Marcovina, S., R. Coppola, M. P. Protti, C. Gelfi, and P. M. Mannucci. "EDTA-DEPENDENT MONOCLONAL ANTIBODIES TO HUMAN PROTEIN S." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644294.

Full text
Abstract:
Splenocytes from a Balb/c mouse immunized with purified human protein S (PS) were fused with murine hybridoma cell line SP2/0-Agl4 and cultured in Iscove's medium without addition of fetal bovine serum. Hybrid supernatants were screened for the presence of specific antibodies by solid-phase ELISA and cloned by the limiting dilution technique. Pour clones, named S2, S3, S8, and S10, were selected, recloned several times, and injected intraperitoneally into Balb/c mice for the production of antibody-rich ascitic fluid. The monoclonal antibodies (Mabs), all of IgGl subclass with k light chain, we
APA, Harvard, Vancouver, ISO, and other styles
7

Vigano D'Angelo, S., F. Gilardoni, M. P. Seveso, A. Marassi, G. Mari, and A. D'Angelo. "REDUCTION OF THE ANTICOAGULANT ACTIVITY OF PROTEIN C AND PROTEIN S DURING THE POSTOPERATIVE PERIOD." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644287.

Full text
Abstract:
Protein S circulates in plasma as free protein S and in complex with C4b-binding protein, an inhibitor of complement activation. Only free protein S functions as the cofactor for the anticoagulant and profibrinolytic effects of activated protein C. Since isolated reductions of protein C and protein S result in increased thrombotic risk, only measurement of both proteins permits comprehensive evaluation of the antithrombotic potential of the protein C system. No information is available on protein C and protein S functional levels during the postoperative period, an established prothrombotic co
APA, Harvard, Vancouver, ISO, and other styles
8

D'Angelo, A., F. Gilardoni, M. P. Seveso, P. Poli, R. Quintavalle, and C. Manotti. "ANTICOAGULANT AND ANTIGENIC LEVELS OF PROTEIN C AND PROTEIN S IN PATIENTS ON STABILIZED ORAL ANTICOAGULANT TREATMENT." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644286.

Full text
Abstract:
Isolated deficiencies of protein C and protein S, two vitamin K-dependent plasma proteins, constitute about 70% of the congenital abnormalities of blood coagulation observed in patients with recurrent venous thrombosis beLow the age of 40. The laboratory diagnosis of congenital deficiency of these proteins represents a major problem since a large proportion of patients are on oral anticoagulation (OA) at the time the deficiencies are suspected.Under these circumstances the availability of a reference interval obtained in patients on stabilized OA has proven useful.Functional (C) and antigenic
APA, Harvard, Vancouver, ISO, and other styles
9

Schwarz, H. P., and W. Muntean. "LOW TOTAL PROTEIN S ANTIGEN BUT HIGH PROTEIN S ACTIVITY DUE TO DECREASED C4b-BINDING PROTEIN (C4b-BP) LEVELS IN NEWBORNS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643610.

Full text
Abstract:
Vitamin K-dependent coagulation proteins are known to be decreased in the neonatal period. So far no data have been published on protein S (PS), the vitamin K-dependent cofactor for the antithrombotic enzyme, activated protein C (APC) in this period. We determined, therefore, PS antigen, PS activity and C4b-BP,a regulatory protein of the classical complement pathway to which PS is complexed, in 36 neonates. Total PS antigen in newborns was below the range associated with thromboembolism in patients congenitally deficient in this protein (22±9.6%, mean±SD). None of these infants had clinical or
APA, Harvard, Vancouver, ISO, and other styles
10

Schwarz, H. P., M. J. Heeb, R. Lottenberg, H. Roberts, and J. H. Griffin. "FAMILIAL PROTEIN S DEFICIENCY WITH A VARIANT PROTEIN S MOLECULE IN PLASMA AND PLATELETS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644636.

Full text
Abstract:
Deficiency of protein S (PS), the cofactor for the antithrombotic protease, activated protein C (APC), was first described in 1984 in families with venous thrombotic disease. We describe here a PS deficient family with venous thrombotic disease presenting an abnormal PS molecule in plasma and platelets. The propositus, 20 years old, and two older siblings suffered from severe venous thrombosis and pulmonary emboli documented by imaging techniques. All laboratory studies were normal except for PS. The propositus while taking oral anticoagulant had a PS antigen (ag) level of 17% and PS functiona
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Protein S"

1

Furbert-Harris, Paulette. Eosinophil Granular Protein(s) Modulate Tumor Metastasis Marker Gene Expression. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada473779.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bercovier, Herve, Raul Barletta, and Shlomo Sela. Characterization and Immunogenicity of Mycobacterium paratuberculosis Secreted and Cellular Proteins. United States Department of Agriculture, 1996. http://dx.doi.org/10.32747/1996.7573078.bard.

Full text
Abstract:
Our long-term goal is to develop an efficient acellular vaccine against paratuberculosis based on protein antigen(s). A prerequisite to achieve this goal is to analyze and characterize Mycobacterium paratuberculosis (Mpt) secreted and cellular proteins eliciting a protective immune response. In the context of this general objective, we proposed to identify, clone, produce, and characterize: the Mpt 85B antigen and other Mpt immunoreactive secreted proteins, the Mpt L7/L12 ribosomal protein and other immunoreactive cellular proteins, Mpt protein determinants involved in invasion of epithelial c
APA, Harvard, Vancouver, ISO, and other styles
3

Citovsky, Vitaly, and Yedidya Gafni. Suppression of RNA Silencing by TYLCV During Viral Infection. United States Department of Agriculture, 2009. http://dx.doi.org/10.32747/2009.7592126.bard.

Full text
Abstract:
The Israeli isolate of Tomato yellow leaf curl geminivirus (TYLCV-Is) is a major tomato pathogen, causing extensive (up to 100%) crop losses in Israel and in the south-eastern U.S. (e.g., Georgia, Florida). Surprisingly, however, little is known about the molecular mechanisms of TYLCV-Is interactions with tomato cells. In the current BARD project, we have identified a TYLCV-Is protein, V2, which acts as a suppressor of RNA silencing, and showed that V2 interacts with the tomato (L. esculentum) member of the SGS3 (LeSGS3) protein family known to be involved in RNA silencing. This proposal will
APA, Harvard, Vancouver, ISO, and other styles
4

Morrison, Mark, and Joshuah Miron. Molecular-Based Analysis of Cellulose Binding Proteins Involved with Adherence to Cellulose by Ruminococcus albus. United States Department of Agriculture, 2000. http://dx.doi.org/10.32747/2000.7695844.bard.

Full text
Abstract:
At the beginning of this project, it was clear that R. albus adhered tightly to cellulose and its efficient degradation of this polysaccharide was dependent on micromolar concentrations of phenylacetic acid (PAA) and phenylpropionic acid (PPA). The objectives for our research were: i) to identify how many different kinds of cellulose binding proteins are produced by Ruminococcus albus; ii) to isolate and clone the genes encoding some of these proteins from the same bacterium; iii) to determine where these various proteins were located and; iv) quantify the relative importance of these proteins
APA, Harvard, Vancouver, ISO, and other styles
5

Christopher, David A., and Avihai Danon. Plant Adaptation to Light Stress: Genetic Regulatory Mechanisms. United States Department of Agriculture, 2004. http://dx.doi.org/10.32747/2004.7586534.bard.

Full text
Abstract:
Original Objectives: 1. Purify and biochemically characterize RB60 orthologs in higher plant chloroplasts; 2. Clone the gene(s) encoding plant RB60 orthologs and determine their structure and expression; 3. Manipulate the expression of RB60; 4. Assay the effects of altered RB60 expression on thylakoid biogenesis and photosynthetic function in plants exposed to different light conditions. In addition, we also examined the gene structure and expression of RB60 orthologs in the non-vascular plant, Physcomitrella patens and cloned the poly(A)-binding protein orthologue (43 kDa RB47-like protein).
APA, Harvard, Vancouver, ISO, and other styles
6

Marquart, Grant. Biomimetic Model Membranes to Study Protein-membrane Interactions and their Role in Alzheimer?s Disease. Portland State University Library, 2015. http://dx.doi.org/10.15760/honors.154.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Grafi, Gideon, and Brian Larkins. Endoreduplication in Maize Endosperm: An Approach for Increasing Crop Productivity. United States Department of Agriculture, 2000. http://dx.doi.org/10.32747/2000.7575285.bard.

Full text
Abstract:
The focus of this research project is to investigate the role of endoreduplication in maize endosperm development and the extent to which this process contributes to high levels of starch and storage protein synthesis. Although endoreduplication has been widely observed in many cells and tissues, especially those with high levels of metabolic activity, the molecular mechanisms through which the cell cycle is altered to produce consecutive cycles of S-phase without an intervening M-phase are unknown. Our previous research has shown that changes in the expression of several cell cycle regulatory
APA, Harvard, Vancouver, ISO, and other styles
8

Thongtan, Thananya, Poonlarp Cheepsunthorn, and Kiat Ruxrungtham. An analysis and studies expression of receptor molecule on microglia cells to inhibits infection of the cells from Japanese encephalitis virus : Research report (Year 2009). Chulalongkorn University, 2009. https://doi.org/10.58837/chula.res.2009.14.

Full text
Abstract:
Japanese encephalitis virus (JEV), a mosquito-borne flavivirus, is a major cause of viral encephalitis in Asia. Even though the principle target cells for JEV in the central nervous system are neurons, the microglia is activated in response to JEV infection. This research aimed to investigate the relationship between JEV and microglial cells. The percentage of JEV infectivity in mouse microglial (BV-2) cell line at 8, 15 and 24 hr post infection was determined by flow cytometry. It was found that the percentage of infected cells were approximately 53.5, 71.3 and 83.6 respectively. The JEV bind
APA, Harvard, Vancouver, ISO, and other styles
9

Yalovsky, Shaul, and Julian Schroeder. The function of protein farnesylation in early events of ABA signal transduction in stomatal guard cells of Arabidopsis. United States Department of Agriculture, 2002. http://dx.doi.org/10.32747/2002.7695873.bard.

Full text
Abstract:
Loss of function mutations in the farnesyltransferase β subunit gene ERA1 (enhanced response to abscisic acid), cause abscisic acid hypersensitivity in seedlings and in guard cells. This results in slowed water loss of plants in response to drought. Farnesyltransferase (PFT) catalyses the attachment of the 15-carbon isoprenoid farnesyl to conserved cysteine residues located in a conserved C-terminal domain designated CaaX box. PFT is a heterodimeric protein comprised of an a and b sununits. The a subunit is shared between PFT and geranylgeranyltransferase-I (PGGTI) which catalyses the attachem
APA, Harvard, Vancouver, ISO, and other styles
10

Evans, Donald L., Avigdor Eldar, Liliana Jaso-Friedmann, and Herve Bercovier. Streptococcus Iniae Infection in Trout and Tilapia: Host-Pathogen Interactions, the Immune Response Towards the Pathogen and Vaccine Formulation. United States Department of Agriculture, 2005. http://dx.doi.org/10.32747/2005.7586538.bard.

Full text
Abstract:
The objectives of the BARD proposal were to determine the mechanisms of nonspecific cytotoxic cells (NCC) that are necessary to provide heightened innate resistance to infection and to identify the antigenic determinants in Streptococcus iniae that are best suited for vaccine development. Our central hypothesis was that anti-bacterial immunity in trout and tilapia can only be acquired by combining "innate" NCC responses with antibody responses to polysaccharide antigens. These Objectives were accomplished by experiments delineated by the following Specific Aims: Specific aim (SA) #1 (USA) "Clo
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!